3,4-dideoxy-4-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-2-C-(hydroxymethyl)-D-epi-inositol,
Basen,
N-(1,3-dihydroxy-2-propyl)valiolamine,
voglibose,
voglibose,
83480-29-9,
Glustat,
Basen,
AO-128,
UNII-S77P977AG8,
A-71100,
CHEMBL476960,
S77P977AG8,
AO 128,
Voglibose [USAN:INN],
Voglibosum [INN-Latin],
Voglibosa [INN-Spanish],
DSSTox_CID_1442,
DSSTox_RID_76161,
DSSTox_GSID_21442,
(1S,2S,3R,4S,5S)-5-((1,3-dihydroxypropan-2-yl)amino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol,
(1S,2S,3R,4S,5S)-5-[(1,3-dihydroxypropan-2-yl)amino]-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol,
CCRIS 4540,
Voglibosum,
Voglibosa,
3,4-Dideoxy-4-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-2-C-(hydroxymethyl)-D-epi-inositol,
Basen OD,
CAS-83480-29-9,
Basen (TN),
A 71100,
Voglibose/,
NCGC00164595-01,
(1S,2S,3R,4S,5S)-5-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino}-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol,
3,4-Dideoxy-4-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-C-(hydroxymethyl)-D-epi-inositol,
AK326133,
VOG,
SCHEMBL5882,
MLS003882582,
Voglibose (JP17/USAN/INN),
DTXSID2021442,
CHEBI:32300,
AOB5593,
FZNCGRZWXLXZSZ-CIQUZCHMSA-N,
BCPP000020,
HMS3414A17,
HMS3678A17,
Voglibose, >=97.0% (TLC),
HY-B0025,
KS-00000H9H,
ZINC3788703,
Tox21_112220,
ABP000769,
BDBM50263044,
BG0525,
CV-051,
s4101,
AKOS015950839,
Tox21_112220_1,
CS-2865,
DB04878,
NCGC00164595-02,
SC-25677,
SMR002530327,
AB1004883,
FT-0630921,
D01665,
AB01566929_01,
480V299,
SR-01000883931,
Q-101310,
Q7939403,
SR-01000883931-1,
BRD-K66850609-001-01-7,
BRD-K66850609-001-07-4,
3,4-DIDEOXY-4-[[2-HYDROXY-1-(HYDROXYMETHYL)ETHYL]A,
(1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol,
3,4-DIDEOXY-4-[[2-HYDROXY-1-(HYDROXYMETHYL)ETHYL]AMINO]-2-C-(HYDROXYMETHYL)-D-EPINOSITOL,
3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine,
Vocarb,
voglistat,
Voglibose [INN],
Volix (Ranbaxy labs),
AC1L9FKA,
D04ZTY,
Basen (Takeda Chemical Industries),
Voglibose (JP15/USAN/INN),
C10H21NO7,
N-(1,3-Dihydroxy-2-propyl)valiolamine,
C10-H21-N-O7,
CID444020,
CS-O-02553,
N-(1,3-Dihydroxyprop-2-yl)valiolamine,
TL8005479,
B1870,
C102817,
(1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol,
3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol,
3,4-Dideoxy-4-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-C-(hydroxymethyl)-D-epiinositol,
5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol,